At 15.8% CAGR, the Europe Breath Analyzer Market is Projected to be Worth US$ 972.12 Million by 2030, says Business Market Insights

According to Business Market Insights research, the Europe breath analyzer market was valued at US$ 300.16 million in 2022 and is expected to reach US$ 972.12 million by 2030, registering a CAGR of 15.8% from 2022 to 2030. Growing alcohol consumption and alcohol-impaired accidents as well as government support and advanced technologies implementation for breath analyzers by key market players are the critical factors attributed to the Europe breath analyzer market expansion.

According to the World Data report published in 2022, the average consumption of alcohol across the world is 6.182 liters per person. The World Health Organization (WHO) reveals that excessive alcohol consumption results in 3 million deaths every year (representing 5.3% of the overall deaths worldwide), causing harm to the well-being and health of people. Additionally, 5.1% of the global burden of disease and injury caused to an individual due to alcohol drunken driving causes social and economic losses to individuals and society. Excessive alcohol consumption results in road traffic crashes and accidents. Estimates from the European Commission indicate that alcohol use contributes to 25% of all traffic fatalities in the EU. One of the three primary causes of death, along with speeding and not wearing a seatbelt, is drunk driving. If all drivers followed the rules against drunk driving, almost 6,500 deaths could be avoided annually. Through the discovery and promotion of best practices as well as the advocacy of relevant legislative measures at the national and EU levels, ETSC seeks to reduce the number of alcohol-related road deaths and injuries. In UK, 2021 witnessed an anticipated 240 fatal drunk driving accidents, the most since 2009. Between 2020 and 2021, there were 4,660 drink-drive collisions of various severity, a 1% increase. This indicates that in 2021, at least one driver or rider who was intoxicated exceeded the legal limit of alcohol consumption in about 5% of all recorded traffic accidents. Therefore, the rising number of deaths due to accidents caused by drunken driving accelerates demand for breath analyzers.

On the contrary, false results by breath analyzers hampers the Europe breath analyzer market.

Based on technology, the Europe breath analyzer market is segmented into fuel cell technology, infrared spectroscopy, semiconductor sensor, and others. The fuel cell technology segment held 58.3% share of Europe breath analyzer market in 2022, amassing US$ 202.44 million. It is projected to garner US$ 595.92 million by 2030 to expand at 16.5% CAGR during 2022-2030.

In terms of application, the Europe breath analyzer market is categorized into alcohol detection, medical applications, and drug abuse detection. The medical applications segment held 50.5% share of Europe breath analyzer market in 2022, amassing US$ 151.63 million. It is projected to garner US$ 515.86 million by 2030 to expand at 16.5% CAGR during 2022-2030.

Based on end user, the Europe breath analyzer market is categorized into hospitals and diagnostic centers, law enforcement agencies, and others. The hospitals and diagnostic centers segment held 46.6% share of Europe breath analyzer market in 2022, amassing US$ 139.87 million. It is projected to garner US$ 444.04 million by 2030 to expand at 15.5% CAGR during 2022-2030.

By country, the Europe breath analyzer market has been categorized into the Germany, France, the UK, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 23.3% share of Europe breath analyzer market in 2022. It was assessed at US$ 69.97 million in 2022 and is likely to hit US$ 247.40 million by 2030, exhibiting a CAGR of 17.1% during 2022-2030.

Key players operating in the Europe breath analyzer market are Thermo Fisher Scientific Inc, Now Group UK Ltd, Dragerwerk AG & Co KGaA, Abbott Laboratories, Honeywell International Inc, KHN Solutions LLC, Bedfont Scientific Ltd, and Intoximeters Inc, among others.

In August-2019, Abbott and Intoximeters entered into an agreement for Intoximeters to market Abbott's SoToxaTM Mobile Test System, a handheld oral fluid roadside testing solution that rapidly and reliably detects recent drug use with Intoximeters' Alco-Sensor brand breath alcohol-testing products. This agreement aided law enforcement agencies in their efforts to reduce the rate of drugged driving, which has become a serious road safety issue.


Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com